FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans-Georg Rammensee

Research Profile

Anatomy

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Sebastian P Haen; Hans-Georg Rammensee
The repertoire of human tumor-associated epitopes - identification and selection of antigens and their application in clinical trials.
Marian Christoph Neidert; Hans-Georg Rammensee; Oliver Schoor; Lisa Christ; Pierre-Yves Dietrich; Christel Herold-Mende; Jürgen Honegger; Arthur Melms; Claudia Trautwein; Nico Trautwein; Stefan Stevanović
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.
Stefanie Bugl; Julia-Stefanie Frick; Rupert Handgretinger; Lothar Kanz; Maya C André; Elke Malenke; Melanie Märklin; Martin R Müller; Markus P Radsak; Hans-Georg Rammensee; Hansjörg Schild; Pamela Stein; Tina Wiesner; Stefan Wirths; Hans-Georg Kopp
Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans-Georg Rammensee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sebastian P Haen; Hans-Georg Rammensee
The repertoire of human tumor-associated epitopes - identification and selection of antigens and their application in clinical trials.
Current opinion in immunology 2013;25(2):277-83.
2013: Marian Christoph Neidert; Hans-Georg Rammensee; Oliver Schoor; Lisa Christ; Pierre-Yves Dietrich; Christel Herold-Mende; Jürgen Honegger; Arthur Melms; Claudia Trautwein; Nico Trautwein; Stefan Stevanović
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.
Journal of neuro-oncology 2013;111(3):285-94.
2013: Stefanie Bugl; Julia-Stefanie Frick; Rupert Handgretinger; Lothar Kanz; Maya C André; Elke Malenke; Melanie Märklin; Martin R Müller; Markus P Radsak; Hans-Georg Rammensee; Hansjörg Schild; Pamela Stein; Tina Wiesner; Stefan Wirths; Hans-Georg Kopp
Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling.
Blood 2013;121(5):723-33.
2013: René Geyeregger; Anita Lawitschka; Thomas Lion; Susanne Matthes; Gabor Mester; Hans-Georg Rammensee; Julia Stemberger; Stefan Stevanovic; Jasmin Dmytrus; Britta Eiz-Vesper; Gottfried Fischer; Christine Freimüller; Gerhard Fritsch
Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application.
PloS one 2013;8(4):e59592.
2013: Theo Sturm; Mathias Walzer; Frank Zufall; Stefan Stevanović; Stephan Jung; Trese Leinders-Zufall; Boris Maček; Peter Overath; Beate Pömmerl; Hans-Georg Rammensee
Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons.
Nature communications 2013;4():1616.
2013: Harpreet Singh-Jasuja; Allan Thiolat; Natacha Bessis; Marie-Christophe Boissier; Hans-Georg Rammensee; Matthieu Ribon; Patrice Decker
The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering.
Immunobiology 2013;218(1):28-39.
2012: Magdalena Feldhahn; Hans-Georg Rammensee; Karin Schilbach; Benjamin Schubert; Pierre Dönnes; Oliver Kohlbacher
miHA-Match: computational detection of tissue-specific minor histocompatibility antigens.
Journal of immunological methods 2012;386(1-2):94-100.
2012: Maya Caroline André; Rupert Handgretinger; Sabrina Kuttruff; Beate Pömmerl; Hans-Georg Rammensee; Dagmar Sigurdardottir; Alexander Steinle
Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
International journal of cancer. Journal international du cancer 2012;131(7):1601-10.
2012: Melanie Widenmeyer; Alexei Y Sazykin; Arnulf Stenzl; Stefan Stevanović; Dorothee Wernet; Sebastian Attig; Susan Feyerabend; Cécile Gouttefangeas; Heinrich Griesemann; Jörg Hennenlotter; Reinhild Klein; Dmitri V Kuprash; Steve Pascolo; Hans-Georg Rammensee
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients.
International journal of cancer. Journal international du cancer 2012;131(1):140-9.
2012: M Hofmann; Steffen Aulwurm; M L Bamberg; Hans-Jörg Bühring; Ludger Grosse-Hovest; S P Haen; T Nübling; E Pyż; Hans-Georg Rammensee; Helmut R Salih; Karin Schilbach; K Schwartz; Gundram Jung
Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.
Leukemia 2012;26(6):1228-37.
2012: Tina Sartorius; Jens Waak; Cora Weigert; Hans-Ulrich Häring; Miriam Hoene; Philipp J Kahle; Stefan Z Lutz; Andreas Peter; Hans-Georg Rammensee; Anita M Hennige
Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(5):1799-809.
2012: Valérie Dutoit; Sylvia Flohr; Jens Fritsche; Christel Herold-Mende; Norbert Hilf; Peter Lewandrowski; Jennifer Lohr; Hans-Georg Rammensee; Oliver Schoor; Harpreet Singh-Jasuja; Stefan Stevanovic; Claudia Trautwein; Verona Vass; Paul R Walker; Steffen Walter; Toni Weinschenk; Philipp Beckhove; Judith Bucher; Katharina Dorsch; Pierre-Yves Dietrich
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.
Brain : a journal of neurology 2012;135(Pt 4):1042-54.
2012: Theresa Placke; Hans-Georg Rammensee; Gundram Jung; Hans-Georg Kopp; Martin Schaller; Melanie Örgel; Helmut R Salih
Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells.
Cancer research 2012;72(2):440-8.
2011: Britta Janina Wagner; Dennis Lindau; Stefan Löb; Hans-Georg Rammensee; Björn L.D.M. Brücher; Jörg Glatzle; Brigitte Gückel; Helen Hörzer; Gerd Klein; Alfred Königsrainer
Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin.
International journal of oncology 2011;39(6):1593-600.
2011: Sebastian P Haen; Bora Kosan; Philippe L Pereira; Hermann Aebert; Andreas Boss; Stephan Clasen; Cécile Gouttefangeas; Diethard Schmidt; Alexandra von Herbay; Hans-Georg Rammensee
Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.
Cell stress & chaperones 2011;16(5):495-504.
2011: Melanie Widenmeyer; Yuriy Shebzukhov; Sebastian P Haen; Diethard Schmidt; Stephan Clasen; Andreas Boss; Dmitri V Kuprash; Sergei A Nedospasov; Arnulf Stenzl; Hermann Aebert; Dorothee Wernet; Stefan Stevanović; Philippe L Pereira; Hans-Georg Rammensee; Cécile Gouttefangeas
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.
International journal of cancer. Journal international du cancer 2011;128(11):2653-62.
2011: Britta Janina Wagner; Dennis Lindau; Dagmar Ripper; York-Dieter Stierhof; Jörg Glatzle; Maria Witte; Henning Beck; Hildegard Keppeler; Kirsten Lauber; Hans-Georg Rammensee; Alfred Königsrainer
Phagocytosis of dying tumor cells by human peritoneal mesothelial cells.
Journal of cell science 2011;124(Pt 10):1644-54.
2011: Susanne M Rittig; Maik Haentschel; Katrin J Weimer; Annkristin Heine; Martin R Muller; Wolfram Brugger; Marius S Horger; Olga Maksimovic; Arnulf Stenzl; Ingmar Hoerr; Hans-Georg Rammensee; Tobias A W Holderried; Lothar Kanz; Steve Pascolo; Peter Brossart
Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(5):990-9.
2011: Dennis Lindau; Viktoria Rönnefarth; Annika Erbacher; Hans-Georg Rammensee; Patrice Decker
Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
European journal of immunology 2011;41(3):669-81.
2011: Juliane S Stickel; Natalie Stickel; Jörg Hennenlotter; Karin Klingel; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation.
BMC urology 2011;11():1.
2010: Tina Baessler; Jean Enno Charton; Benjamin Joachim Schmiedel; Frank Grünebach; Matthias Krusch; Alexander Wacker; Hans-Georg Rammensee; Helmut R Salih
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Blood 2010;115(15):3058-69.
2010: Celine Serangeli; Oliver Bicanic; Michael H Scheible; Dorothee Wernet; Peter Lang; Hans-Georg Rammensee; Stefan Stevanovic; Rupert Handgretinger; Tobias Feuchtinger
Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation.
Virology 2010;397(2):277-84.
2010: Stella Eugenie Autenrieth; Tanja-Rebecca Linzer; Clara Hiller; Birgit Keller; Philipp Warnke; Martin Köberle; Erwin Bohn; Tilo Biedermann; Hans-Jörg Bühring; Günter J Hämmerling; Hans-Georg Rammensee; Ingo B Autenrieth
Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.
PLoS pathogens 2010;6(11):e1001212.
2009: Katrin Bürk; Marie-Louise Farecki; Georg Lamprecht; Guenter Roth; Patrice Decker; Michael Weller; Hans-Georg Rammensee; Wolfang Oertel
Neurological symptoms in patients with biopsy proven celiac disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(16):2358-62.
2009: Jan Wahlström; Jörn Dengjel; Ola Winqvist; Ira Targoff; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Anders Eklund; Robert Weissert; Johan Grunewald
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis.
Clinical immunology (Orlando, Fla.) 2009;133(3):353-63.
2009: Sebastian Attig; Jörg Hennenlotter; Graham Pawelec; Gerd Klein; Sven D Koch; Hanspeter Pircher; Susan Feyerabend; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Cécile Gouttefangeas
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
Cancer research 2009;69(21):8412-9.
2009: Anita M Hennige; T Sartorius; S Z Lutz; Otto Tschritter; Hubert Preissl; S Hopp; Andreas Fritsche; Hans-Georg Rammensee; P Ruth; Hans-Ulrich Häring
Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity.
Diabetologia 2009;52(11):2416-24.
2009: Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans-Georg Rammensee; Robert Weissert
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Molecular & cellular proteomics : MCP 2009;8(9):2090-101.
2009: Juliane Sarah Stickel; Andreas O Weinzierl; Nina Hillen; Oliver Drews; Mathias M Schuler; Jörg Hennenlotter; Dorothee Wernet; Claudia A Müller; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Cancer immunology, immunotherapy : CII 2009;58(9):1407-17.
2009: Jan Diekmann; Eleni Adamopoulou; Olaf Beck; Georg Rauser; Sarah Lurati; Stefan Tenzer; Hermann Einsele; Hans-Georg Rammensee; Hansjörg Schild; Max S Topp
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(3):1587-97.
2009: Verena S Meyer; Oliver Drews; Marc Günder; Jörg Hennenlotter; Hans-Georg Rammensee; Stefan Stevanovic
Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands.
Journal of proteome research 2009;8(7):3666-74.
2009: Susan Feyerabend; Stefan Stevanovic; Cécile Gouttefangeas; Dorothee Wernet; Jörg Hennenlotter; Jens Bedke; Klaus Dietz; Steve Pascolo; Markus Kuczyk; Hans-Georg Rammensee; Arnulf Stenzl
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.
The Prostate 2009;69(9):917-27.
2009: Benjamin Weide; Steve Pascolo; Birgit Scheel; Evelyna Derhovanessian; Annette Pflugfelder; Thomas K Eigentler; Graham Pawelec; Ingmar Hoerr; Hans-Georg Rammensee; Claus Garbe
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(5):498-507.
2009: Stefan Löb; Alfred Königsrainer; Hans-Georg Rammensee; Gerhard Opelz; Peter Terness
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Nature reviews. Cancer 2009;9(6):445-52.
2009: Anne Marie Asemissen; Doreen Haase; Stefan Stevanovic; Sandra Bauer; Antonia Busse; Eckhard Thiel; Hans-Georg Rammensee; Ulrich Keilholz; Carmen Scheibenbogen
Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(4):370-5.
2009: Sabrina Kuttruff; Sven Koch; Alexandra Kelp; Graham Pawelec; Hans-Georg Rammensee; Alexander Steinle
NKp80 defines and stimulates a reactive subset of CD8 T cells.
Blood 2009;113(2):358-69.
2009: T Otz; Ludger Grosse-Hovest; M Hofmann; Hans-Georg Rammensee; Gundram Jung
A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells.
Leukemia 2009;23(1):71-7.
2009: Stefan Löb; Alfred Königsrainer; Derek Zieker; Björn L.D.M. Brücher; Hans-Georg Rammensee; Gerhard Opelz; Peter Terness
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Cancer immunology, immunotherapy : CII 2009;58(1):153-7.
2008: Mercedes Kloss; Patrice Decker; Katrin M Baltz; Tina Baessler; Gundram Jung; Hans-Georg Rammensee; Alexander Steinle; Matthias Krusch; Helmut R Salih
Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(10):6711-9.
2008: Nina Hillen; Gabor Mester; Claudia Lemmel; Andreas O Weinzierl; Margret Müller; Dorothee Wernet; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
European journal of immunology 2008;38(11):2993-3003.
2008: Verena S Meyer; Wolfgang Kastenmuller; Georg Gasteiger; Mirita Franz-Wachtel; Tobias Lamkemeyer; Hans-Georg Rammensee; Stefan Stevanovic; Dagmar Sigurdardottir; Ingo Drexler
Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(9):6371-83.
2008: Yuko Yokoyama; Frank Grünebach; Susanne M Schmidt; Annkristin Heine; Maik Häntschel; Stefan Stevanovic; Hans-Georg Rammensee; Peter Brossart
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5503-11.
2008: Andreas O Weinzierl; Despina Rudolf; Dominik Maurer; Dorothee Wernet; Hans-Georg Rammensee; Stefan Stevanović; Karin Klingel
Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses.
The Journal of general virology 2008;89(Pt 9):2090-7.
2008: Inja Waldhauer; Dennis Goehlsdorf; Friederike Gieseke; Toni Weinschenk; Mareike Wittenbrink; Andreas Ludwig; Stefan Stevanovic; Hans-Georg Rammensee; Alexander Steinle
Tumor-associated MICA is shed by ADAM proteases.
Cancer research 2008;68(15):6368-76.
2008: Andreas O Weinzierl; Gudrun Szalay; Hartwig Wolburg; Martina Sauter; Hans-Georg Rammensee; Reinhard Kandolf; Stefan Stevanović; Karin Klingel
Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.
Journal of virology 2008;82(16):8149-60.
2008: Magdalena Feldhahn; Philipp Thiel; Mathias M Schuler; Nina Hillen; Stefan Stevanovic; Hans-Georg Rammensee; Oliver Kohlbacher
EpiToolKit--a web server for computational immunomics.
Nucleic acids research 2008;36(Web Server issue):W519-22.
2008: Andreas O Weinzierl; Despina Rudolf; Nina Hillen; Stefan Tenzer; Peter van Endert; Hansjörg Schild; Hans-Georg Rammensee; Stefan Stevanović
Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
European journal of immunology 2008;38(6):1503-10.
2008: Andreas O Weinzierl; Dominik Maurer; Florian Altenberend; Nicole Schneiderhan-Marra; Karin Klingel; Oliver Schoor; Dorothee Wernet; Thomas Joos; Hans-Georg Rammensee; Stefan Stevanović
A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.
Cancer research 2008;68(7):2447-54.
2008: Mark M Schatz; Björn Peters; Nadja Akkad; Nina Ullrich; Alejandra Nacarino Martinez; Oliver Carroll; Sascha Bulik; Hans-Georg Rammensee; Peter van Endert; Hermann-Georg Holzhütter; Stefan Tenzer; Hansjörg Schild
Characterizing the N-terminal processing motif of MHC class I ligands.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):3210-7.
2008: Tanja Herrmann; Ludger Grosse-Hovest; Tina Otz; Peter H Krammer; Hans-Georg Rammensee; Gundram Jung
Construction of optimized bispecific antibodies for selective activation of the death receptor CD95.
Cancer research 2008;68(4):1221-7.
2008: Stefan Lob; Alfred Konigsrainer; Richard Schafer; Hans-Georg Rammensee; Gerhard Opelz; Peter Terness
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.
Blood 2008;111(4):2152-4.
2008: Despina Rudolf; Tobias Silberzahn; Steffen Walter; Dominik Maurer; Johanna Engelhard; Dorothee Wernet; Hans-Jörg Bühring; Gundram Jung; Byoung S Kwon; Hans-Georg Rammensee; Stefan Stevanović
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
Cancer immunology, immunotherapy : CII 2008;57(2):175-83.
2008: Benjamin Weide; Claus Garbe; Hans-Georg Rammensee; Steve Pascolo
Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
Immunology letters 2008;115(1):33-42.
2007: Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
The Journal of clinical investigation 2007;117(11):3576-82.
2007: Jochen Probst; Benjamin Weide; Birgit Scheel; Bernd J Pichler; Ingmar Hoerr; Hans-Georg Rammensee; Steve Pascolo
Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent.
Gene therapy 2007;14(15):1175-80.
2007: Katrin M Baltz; Matthias Krusch; Anita Bringmann; Peter Brossart; Frank Mayer; Mercedes Kloss; Tina Baessler; Ingrid Kumbier; Andrea Peterfi; Susan Kupka; Stefan Kroeber; Dagmar Menzel; Markus P Radsak; Hans-Georg Rammensee; Helmut R Salih
Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(10):2442-54.
2007: Cristina N Boss; Frank Grünebach; Katharina M Brauer; Maik Häntschel; Valdete Mirakaj; Toni Weinschenk; Stefan Stevanovic; Hans-Georg Rammensee; Peter Brossart
Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3347-55.
2007: Eleni Adamopoulou; Jan Diekmann; Eva Tolosa; Gaby Kuntz; Hermann Einsele; Hans-Georg Rammensee; Max S Topp
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(9):5465-72.
2007: Frank Röck; Karl-Peter Hadeler; Hans-Georg Rammensee; Peter Overath
Quantitative analysis of mouse urine volatiles: in search of MHC-dependent differences.
PloS one 2007;2(5):e429.
2007: Andreas O Weinzierl; Claudia Lemmel; Oliver Schoor; Margret Müller; Tobias Krüger; Dorothee Wernet; Jörg Hennenlotter; Arnulf Stenzl; Karin Klingel; Hans-Georg Rammensee; Stefan Stevanovic
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface.
Molecular & cellular proteomics : MCP 2007;6(1):102-13.
2007: Cécile Gouttefangeas; Arnulf Stenzl; Stefan Stevanović; Hans-Georg Rammensee
Immunotherapy of renal cell carcinoma.
Cancer immunology, immunotherapy : CII 2007;56(1):117-28.
2006: Anne Marie Asemissen; Ulrich Keilholz; Stefan Tenzer; Margret Müller; Steffen Walter; Stefan Stevanovic; Hansjörg Schild; Anne Letsch; Eckhard Thiel; Hans-Georg Rammensee; Carmen Scheibenbogen
Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7476-82.
2006: Viktoria M Rönnefarth; Annika I M Erbacher; Tobias Lamkemeyer; Johannes Madlung; Alfred Nordheim; Hans-Georg Rammensee; Patrice Decker
TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(11):7740-9.
2006: Hans-Georg Rammensee
Peptides made to order.
Immunity 2006;25(5):693-5.
2006: Birgit Scheel; Steffen Aulwurm; Jochen Probst; Lothar Stitz; Ingmar Hoerr; Hans-Georg Rammensee; Michael Weller; Steve Pascolo
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.
European journal of immunology 2006;36(10):2807-16.
2006: Gerd Rechtsteiner; Tobias Warger; Matthias Hofmann; Hans-Georg Rammensee; Hansjörg Schild; Markus P Radsak
Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo.
European journal of immunology 2006;36(10):2613-23.
2006: Kirsten Falk; Olaf Rötzschke; Stefan Stevanović; Günther Jung; Hans-Georg Rammensee
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. 1991.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(5):2741-7.
2006: Patrice Decker; Ina Kötter; Reinhild Klein; Beate Berner; Hans-Georg Rammensee
Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2006;45(9):1087-95.
2006: Tobias Warger; Norbert Hilf; Gerd Rechtsteiner; Philipp Haselmayer; Deanna M Carrick; Helmut Jonuleit; Philipp von Landenberg; Hans-Georg Rammensee; Christopher V Nicchitta; Markus P Radsak; Hansjörg Schild
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses.
The Journal of biological chemistry 2006;281(32):22545-53.
2006: Jörn Dengjel; Maria-Dorothea Nastke; Cécile Gouttefangeas; Gitsios Gitsioudis; Oliver Schoor; Florian Altenberend; Margret Müller; Björn Krämer; Anna Missiou; Martina Sauter; Jörg Hennenlotter; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Karin Klingel; Stefan Stevanović
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4163-70.
2006: Frank Röck; Sven Mueller; Udo Weimar; Hans-Georg Rammensee; Peter Overath
Comparative analysis of volatile constituents from mice and their urine.
Journal of chemical ecology 2006;32(6):1333-46.
2006: Hans-Georg Rammensee
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer.
Immunology and cell biology 2006;84(3):290-4.
2006: Philipp Osterloh; Kathrin Linkemann; Stefan Tenzer; Hans-Georg Rammensee; Markus P Radsak; Dirk H Busch; Hansjörg Schild
Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(13):5042-7.
2006: Jochen Probst; Sonja Brechtel; Birgit Scheel; Ingmar Hoerr; Günther Jung; Hans-Georg Rammensee; Steve Pascolo
Characterization of the ribonuclease activity on the skin surface.
Genetic vaccines and therapy 2006;4():4.
2005: Ludger Grosse-Hovest; Wolfgang Wick; Rosa Minoia; Michael Weller; Hans-Georg Rammensee; Gottfried Brem; Gundram Jung
Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 2005;117(6):1060-4.
2005: Mathias M Schuler; Pierre Dönnes; Maria-Dorothea Nastke; Oliver Kohlbacher; Hans-Georg Rammensee; Stefan Stevanovic
SNEP: SNP-derived epitope prediction program for minor H antigens.
Immunogenetics 2005;57(11):816-20.
2005: Steffen Walter; Gilles Bioley; Hans-Jörg Bühring; Sven Koch; Dorothee Wernet; Alfred Zippelius; Graham Pawelec; Pedro Romero; Stefan Stevanović; Hans-Georg Rammensee; Cécile Gouttefangeas
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.
European journal of immunology 2005;35(10):2876-85.
2005: Björn F Krämer; Oliver Schoor; Tobias Krüger; Christian Reichle; Margret Müller; Toni Weinschenk; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanovic
MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue.
Cancer biology & therapy 2005;4(9):943-8.
2005: Tobias Krüger; Oliver Schoor; Claudia Lemmel; Bjoern Kraemer; Christian Reichle; Jörn Dengjel; Toni Weinschenk; Margret Müller; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
Cancer immunology, immunotherapy : CII 2005;54(9):826-36.
2005: Jean-Philippe Carralot; Benjamin Weide; Oliver Schoor; Jochen Probst; Birgit Scheel; Regina Teufel; Ingmar Hoerr; Claus Garbe; Hans-Georg Rammensee; Steve Pascolo
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.
Genetic vaccines and therapy 2005;3():6.
2005: Anne Tammiruusu; A Haveri; Steve Pascolo; Riitta Lahesmaa; Stefan Stevanovic; Hans-Georg Rammensee; Matti Sarvas; Mirja Puolakkainen; Jenni M Vuola
Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
Scandinavian journal of immunology 2005;62(2):131-9.
2005: Regina Teufel; Jean-Philippe Carralot; Birgit Scheel; Jochen Probst; Steffen Walter; Günther Jung; Ingmar Hoerr; Hans-Georg Rammensee; Steve Pascolo
Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro.
Cellular and molecular life sciences : CMLS 2005;62(15):1755-62.
2005: Jasmin Dittmann; Karin Keller-Matschke; Toni Weinschenk; Thomas Kratt; Tobias Heck; Horst D Becker; Stefan Stevanović; Hans-Georg Rammensee; Cécile Gouttefangeas
CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.
Cancer immunology, immunotherapy : CII 2005;54(8):750-8.
2005: Sylvia Herter; Philipp Osterloh; Norbert Hilf; Gerd Rechtsteiner; Jörg Höhfeld; Hans-Georg Rammensee; Hansjörg Schild
Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):891-8.
2005: Katrin Wiemann; Hans-Willi Mittrücker; Ute Feger; Stefan Welte; Wayne M Yokoyama; Thomas Spies; Hans-Georg Rammensee; Alexander Steinle
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):720-9.
2005: Karin Schilbach; Gunter Kerst; Steffen Walter; Matthias Eyrich; Dorothee Wernet; Rupert Handgretinger; WeiDong Xie; Hans-Georg Rammensee; Ingo Müller; Hans-Jörg Bühring; Dietrich Niethammer
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Blood 2005;106(1):144-9.
2005: Jörn Dengjel; Oliver Schoor; Rainer Fischer; Michael Reich; Marianne Kraus; Margret Müller; Katharina Kreymborg; Florian Altenberend; Jens Brandenburg; Hubert Kalbacher; Roland Brock; Christoph Driessen; Hans-Georg Rammensee; Stefan Stevanovic
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(22):7922-7.
2005: Stefan Tenzer; Björn Peters; Sascha Bulik; Oliver Schoor; Claudia Lemmel; M M Schatz; Peter-M Kloetzel; Hans-Georg Rammensee; Hansjörg Schild; Hermann-Georg Holzhütter
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding.
Cellular and molecular life sciences : CMLS 2005;62(9):1025-37.
2005: Birgit Scheel; Regina Teufel; Jochen Probst; Jean-Philippe Carralot; Jens Geginat; Markus Radsak; David Jarrossay; Hermann Wagner; Günther Jung; Hans-Georg Rammensee; Ingmar Hoerr; Steve Pascolo
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.
European journal of immunology 2005;35(5):1557-66.
2005: Jean-Philippe Carralot; Claudia Dumrese; Ralf Wessel; Reimer Riessen; Ingo B Autenrieth; Steffen Walter; Oliver Schoor; Stefan Stevanovic; Hans-Georg Rammensee; Steve Pascolo
CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients.
International immunology 2005;17(5):591-7.
2005: Patrice Decker; Harpreet Singh-Jasuja; Sabine Haager; Ina Kötter; Hans-Georg Rammensee
Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3326-34.
2005: Steve Pascolo; Ginhoux Florent; Nihay Laham; Steffen Walter; Oliver Schoor; Jochen Probst; Pierre-Simon Rohrlich; Florian Obermayr; Paul Fisch; Olivier Danos; Rachel Ehrlich; François A Lemonnier; Hans-Georg Rammensee
The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells.
International immunology 2005;17(2):117-22.
2005: Sabina Rayo Ramirez; Harpreet Singh-Jasuja; Tobias Warger; Sibylla Braedel-Ruoff; Norbert Hilf; Katrin Wiemann; Hans-Georg Rammensee; Hansjörg Schild
Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response.
Cell stress & chaperones 2005;10(3):221-9.
2005: Jörn Dengjel; Hans-Georg Rammensee; Stefan Stevanovic
Glycan side chains on naturally presented MHC class II ligands.
Journal of mass spectrometry : JMS 2005;40(1):100-4.
2005: Maria-Dorothea Nastke; L Herrgen; Steffen Walter; Dorothee Wernet; Hans-Georg Rammensee; S Stevanović
Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Cellular and molecular life sciences : CMLS 2005;62(1):77-86.
2004: Jörn Dengjel; Patrice Decker; Oliver Schoor; Florian Altenberend; Toni Weinschenk; Hans-Georg Rammensee; Stefan Stevanovic
Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry.
European journal of immunology 2004;34(12):3644-51.
2004: Jean-Philippe Carralot; Jochen Probst; Ingmar Hoerr; Birgit Scheel; Regina Teufel; Günther Jung; Hans-Georg Rammensee; Steve Pascolo
Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines.
Cellular and molecular life sciences : CMLS 2004;61(18):2418-24.
2004: Jochen Probst; Sibylle G Blumenthal; Stefan Tenzer; Toni Weinschenk; Jürgen Dittmer; Oliver Schoor; Adrien Six; Hans-Georg Rammensee; Steve Pascolo
A conserved sequence in the mouse variable T cell receptor alpha recombination signal sequence 23-bp spacer can affect recombination.
European journal of immunology 2004;34(8):2179-90.
2004: Matthias Hofmann; Markus P Radsak; Gerd Rechtsteiner; Katrin Wiemann; Marc Günder; Ursula Bien-Gräter; Rienk Offringa; René E M Toes; Hans-Georg Rammensee; Hansjörg Schild
T cell avidity determines the level of CTL activation.
European journal of immunology 2004;34(7):1798-806.
2004: Frank Neumann; Claudia Wagner; Boris Kubuschok; Stefan Stevanovic; Hans-Georg Rammensee; Michael Pfreundschuh
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes.
Cancer immunology, immunotherapy : CII 2004;53(7):589-99.
2004: Kerstin Schag; Susanne M Schmidt; Martin R Müller; Toni Weinschenk; Silke Appel; Markus M Weck; Frank Grünebach; Stefan Stevanovic; Hans-Georg Rammensee; Peter Brossart
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3658-66.
2004: Markus P Radsak; Helmut R Salih; Hans-Georg Rammensee; Hansjörg Schild
Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(8):4956-63.
2004: Claudia Lemmel; Steffen Weik; Ute Eberle; Jörn Dengjel; Thomas Kratt; Horst-Dieter Becker; Hans-Georg Rammensee; Stefan Stevanovic
Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.
Nature biotechnology 2004;22(4):450-4.
2004: Brigitte Kircher; Maria Wolf; Stefan Stevanovic; Hans-Georg Rammensee; Beatrix Grubeck-Loebenstein; Guenther Gastl; David Nachbaur
Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusion.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(2):156-60.
2004: Harpreet Singh-Jasuja; Niels P N Emmerich; Hans-Georg Rammensee
The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.
Cancer immunology, immunotherapy : CII 2004;53(3):187-95.
2004: Susanne M Schmidt; Kerstin Schag; Martin R Müller; Toni Weinschenk; Silke Appel; Oliver Schoor; Markus M Weck; Frank Grünebach; Lothar Kanz; Stefan Stevanovic; Hans-Georg Rammensee; Peter Brossart
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
Cancer research 2004;64(3):1164-70.
2004: Birgit Scheel; Sybilla Braedel; Jochen Probst; Jean-Philippe Carralot; Hermann Wagner; Hansjorg Schild; Günther Jung; Hans-Georg Rammensee; Steve Pascolo
Immunostimulating capacities of stabilized RNA molecules.
European journal of immunology 2004;34(2):537-47.
2004: Hans-Georg Rammensee
Immunology: protein surgery.
Nature 2004;427(6971):203-4.
2004: Stefan Tenzer; Lars Stoltze; Birgitt Schönfisch; Jörn Dengjel; Margret Müller; Stefan Stevanović; Hans-Georg Rammensee; Hansjörg Schild
Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(2):1083-91.
2003: Claudia Wagner; Frank Neumann; Boris Kubuschok; Evi Regitz; Axel Mischo; Stefan Stevanovic; Michael Friedrich; Werner Schmidt; Hans-Georg Rammensee; Michael Pfreundschuh
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.
Cancer immunity 2003;3():18.
2003: Manuel A Friese; Michael Platten; Stefan Z Lutz; Ulrike Naumann; Steffen Aulwurm; Felix Bischof; Hans-Jörg Bühring; Johannes Dichgans; Hans-Georg Rammensee; Alexander Steinle; Michael Weller
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Cancer research 2003;63(24):8996-9006.
2003: Oliver Schoor; Toni Weinschenk; Jörg Hennenlotter; Stefan Corvin; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Moderate degradation does not preclude microarray analysis of small amounts of RNA.
BioTechniques 2003;35(6):1192-6, 1198-201.
2003: Steffen Walter; Leah Herrgen; Oliver Schoor; Gundram Jung; Dorothee Wernet; Hans-Jörg Bühring; Hans-Georg Rammensee; Stefan Stevanović
Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(10):4974-8.
2003: Holger Hebart; Georg Rauser; Stefan Stevanovic; Claire Haenle; Alexander K Nussbaum; Christoph Meisner; Alfred Lennart Bissinger; Stefan Tenzer; Gerhard Jahn; Juergen Loeffler; Hans-Georg Rammensee; Hansjörg Schild; Hermann Einsele
A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.
Experimental hematology 2003;31(10):966-73.
2003: Helmut R Salih; Holger Antropius; Friederike Gieseke; Stefan Zoltan Lutz; Lothar Kanz; Hans-Georg Rammensee; Alexander Steinle
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.
Blood 2003;102(4):1389-96.
2003: Patrice Decker; Hartwig Wolburg; Hans-Georg Rammensee
Nucleosomes induce lymphocyte necrosis.
European journal of immunology 2003;33(7):1978-87.
2003: Ludger Grosse-Hovest; Ingo Hartlapp; Wolfgang Marwan; Gottfried Brem; Hans-Georg Rammensee; Gundram Jung
A recombinant bispecific single-chain antibody induces targeted, supra-agonistic CD28-stimulation and tumor cell killing.
European journal of immunology 2003;33(5):1334-40.
2003: Markus P Radsak; Norbert Hilf; Harpreet Singh-Jasuja; Sibylla Braedel; Peter Brossart; Hans-Georg Rammensee; Hansjörg Schild
The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions.
Blood 2003;101(7):2810-5.
2003: Lars Stoltze; Human Rezaei; Günther Jung; Jeanne Grosclaude; Pascale Debey; Hansjörg Schild; Hans-Georg Rammensee
CD4+ T cell-mediated immunity against prion proteins.
Cellular and molecular life sciences : CMLS 2003;60(3):629-38.
2003: Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanović; Burkhard Schmidt; François A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(1):217-22.
2003: Joerg Hakenberg; Alexander K Nussbaum; Hansjörg Schild; Hans-Georg Rammensee; Christina Kuttler; Hermann-Georg Holzhütter; Peter-M Kloetzel; Stefan H E Kaufmann; Hans-Joachim Mollenkopf
MAPPP: MHC class I antigenic peptide processing prediction.
Applied bioinformatics 2003;2(3):155-8.
2003: Hans-Georg Rammensee
Immunoinformatics: bioinformatic strategies for better understanding of immune function. Introduction.
Novartis Foundation symposium 2003;254():1-2.
2003: Stefan Welte; Christian Sinzger; Stefan Z Lutz; Harpreet Singh-Jasuja; Kerstin Laib Sampaio; Ute Eknigk; Hans-Georg Rammensee; Alexander Steinle
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
European journal of immunology 2003;33(1):194-203.
2003: Karl S Lang; Cora Weigert; Sibylla Braedel; Sophie Fillon; Monica Palmada; Erwin Schleicher; Hans-Georg Rammensee; Florian Lang
Inhibition of interferon-gamma expression by osmotic shrinkage of peripheral blood lymphocytes.
American journal of physiology. Cell physiology 2003;284(1):C200-8.
2003: Christian Kleist; Danièle Arnold-Schild; Martin Welschof; Martina Finger; Gerhard Opelz; Hans-Georg Rammensee; Hansjörg Schild; Peter Terness
Single-chain Fv-based affinity purification of the cellular stress protein gp96 for vaccine development.
Methods in molecular biology (Clifton, N.J.) 2003;207():393-420.
2002: Kenji Yoshida; Tracy Martin; Ken Yamamoto; Cathleen Dobbs; Christian Münz; Nobuhiro Kamikawaji; Naoko Nakano; Hans-Georg Rammensee; Takehiko Sasazuki; Kathryn Haskins; Hitoshi Kikutani
Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.
International immunology 2002;14(12):1439-47.
2002: Toni Weinschenk; Cécile Gouttefangeas; Markus Schirle; Florian Obermayr; Steffen Walter; Oliver Schoor; Raffael Kurek; Wolfgang Loeser; Karl-Horst Bichler; Dorothee Wernet; Stefan Stevanović; Hans-Georg Rammensee
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Cancer research 2002;62(20):5818-27.
2002: Helmut R Salih; Hans-Georg Rammensee; Alexander Steinle
Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(8):4098-102.
2002: Hans-Georg Rammensee
Survival of the fitters.
Nature 2002;419(6906):443-5.
2002: Hans-Georg Rammensee; Toni Weinschenk; Cécile Gouttefangeas; Stefan Stevanović
Towards patient-specific tumor antigen selection for vaccination.
Immunological reviews 2002;188():164-76.
2002: Christian Münz; Matthias Hofmann; Kenji Yoshida; Antonis K Moustakas; Hitoshi Kikutani; Stefan Stevanoviç; George K Papadopoulos; Hans-Georg Rammensee
Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).
European journal of immunology 2002;32(8):2105-16.
2002: Anne Sarén; Steve Pascolo; Stefan Stevanovic; Tilman Dumrese; Mirja Puolakkainen; Matti Sarvas; Hans-Georg Rammensee; Jenni M Vuola
Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.
Infection and immunity 2002;70(7):3336-43.
2002: Ramunas M Vabulas; Sibylla Braedel; Norbert Hilf; Harpreet Singh-Jasuja; Sylvia Herter; Parviz Ahmad-Nejad; Carsten J Kirschning; Clarissa Da Costa; Hans-Georg Rammensee; Hermann Wagner; Hansjörg Schild
The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway.
The Journal of biological chemistry 2002;277(23):20847-53.
2002: Karl S Lang; Arnaud Moris; Cécile Gouttefangeas; Steffen Walter; Volker Teichgräber; M Miller; Dorothee Wernet; Klaus Hamprecht; Hans-Georg Rammensee; Stefan Stevanovic
High frequency of human cytomegalovirus (HCMV)-specific CD8+ T cells detected in a healthy CMV-seropositive donor.
Cellular and molecular life sciences : CMLS 2002;59(6):1076-80.
2002: Brigitte Kircher; Stefan Stevanovic; Martina Urbanek; Andrea Mitterschiffthaler; Hans-Georg Rammensee; Kurt Grünewald; Guenther Gastl; David Nachbaur
Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion.
British journal of haematology 2002;117(4):935-9.
2002: Hermann Einsele; Eddy Roosnek; Nathalie Rufer; Christian Sinzger; Susanne Riegler; Jürgen Löffler; Ulrich Grigoleit; Arnaud Moris; Hans-Georg Rammensee; Lothar Kanz; Annette Kleihauer; Friederike Frank; Gerhard Jahn; Holger Hebart
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.
Blood 2002;99(11):3916-22.
2002: Holger Hebart; Senay Daginik; Stefan Stevanovic; Ulrich Grigoleit; Andrea Dobler; Manuela Baur; Georg Rauser; Christian Sinzger; Gerhard Jahn; Juergen Loeffler; Lothar Kanz; Hans-Georg Rammensee; Hermann Einsele
Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
Blood 2002;99(10):3830-7.
2002: Norbert Hilf; Harpreet Singh-Jasuja; Petra Schwarzmaier; Cécile Gouttefangeas; Hans-Georg Rammensee; Hansjörg Schild
Human platelets express heat shock protein receptors and regulate dendritic cell maturation.
Blood 2002;99(10):3676-82.
2002: Jan T Maier; Markus Haug; Jürgen L Föll; Hermann Beck; Hubert Kalbacher; Hans-Georg Rammensee; Guenther E Dannecker
Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
Immunogenetics 2002;54(2):67-73.
2002: Jörg Wischhusen; Gundram Jung; Ivan Radovanovic; Christoph P Beier; Joachim P Steinbach; Andreas Rimner; Huatao Huang; Jörg B Schulz; Hiroko Ohgaki; Adriano Aguzzi; Hans-Georg Rammensee; Michael Weller
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Cancer research 2002;62(9):2592-9.
2002: Carmen Scheibenbogen; Yuansheng Sun; Ulrich Keilholz; Mingxia Song; Stefan Stevanovic; Anne Marie Asemissen; Dirk Nagorsen; Eckhard Thiel; Hans-Georg Rammensee; Dirk Schadendorf
Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.
International journal of cancer. Journal international du cancer 2002;98(3):409-14.
2002: Karl S Lang; Sophie Fillon; D Schneider; Hans-Georg Rammensee; Florian Lang
Stimulation of TNF alpha expression by hyperosmotic stress.
Pflügers Archiv : European journal of physiology 2002;443(5-6):798-803.
2002: Maha Ayyoub; Stefan Stevanovic; Ugur Sahin; Philippe Guillaume; Catherine Servis; Donata Rimoldi; Danila Valmori; Pedro Romero; Jean-Charles Cerottini; Hans-Georg Rammensee; Michael Pfreundschuh; Daniel Speiser; Frédéric Lévy
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1717-22.
2001: S Montag; M Frank; H Ulmer; Dorothee Wernet; W Göpel; Hans-Georg Rammensee
"Electronic nose" detects major histocompatibility complex-dependent prerenal and postrenal odor components.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):9249-54.
2001: René E M Toes; Alexander K Nussbaum; S Degermann; Markus Schirle; Niels P N Emmerich; M Kraft; C Laplace; A Zwinderman; TP Dick; J Müller; Birgitt Schönfisch; C Schmid; Hans Jörg Fehling; Stefan Stevanovic; Hans-Georg Rammensee; Hansjörg Schild
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.
The Journal of experimental medicine 2001;194(1):1-12.
2001: Arnaud Moris; Dorothee Wernet; S Stevanović; Hans-Georg Rammensee
The peptide-specific alloreactive human T cell repertoire varies largely between individuals and is not extended in HLA-A*0205--anti-HLA-A*0201 pairings.
International immunology 2001;13(7):863-70.
2001: Cécile Gouttefangeas; M Eberle; Peter Ruck; M Stark; J E Müller; Horst D Becker; Hans-Georg Rammensee; Jürgen Pinocy
Functional T lymphocytes infiltrate implanted polyvinyl alcohol foams during surgical wound closure therapy.
Clinical and experimental immunology 2001;124(3):398-405.
2001: Karl S Lang; C C Caroli; A Muhm; Dorothee Wernet; Arnaud Moris; Birgit Schittek; E Knauss-Scherwitz; Stefan Stevanovic; Hans-Georg Rammensee; Claus Garbe
HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
The Journal of investigative dermatology 2001;116(6):891-7.
2001: Steve Pascolo; Markus Schirle; Brigitte Gückel; Tilman Dumrese; Susanne Stumm; Simone Kayser; Arnaud Moris; Diethelm Wallwiener; Hans-Georg Rammensee; Stefan Stevanovic
A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry.
Cancer research 2001;61(10):4072-7.
2001: Arnaud Moris; Volker Teichgräber; L Gauthier; Hans-Jörg Bühring; Hans-Georg Rammensee
Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(8):4818-21.
2001: Annette Kleihauer; Ulrich Grigoleit; Holger Hebart; Arnaud Moris; Peter Brossart; A Muhm; Stefan Stevanovic; Hans-Georg Rammensee; Christian Sinzger; Susanne Riegler; Gerhard Jahn; Lothar Kanz; Hermann Einsele
Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells.
British journal of haematology 2001;113(1):231-9.
2001: Alexander K Nussbaum; Christina Kuttler; Karl-Peter Hadeler; Hans-Georg Rammensee; Hansjörg Schild
PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.
Immunogenetics 2001;53(2):87-94.
2001: Gundram Jung; Ludger Grosse-Hovest; P H Krammer; Hans-Georg Rammensee
Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments.
Cancer research 2001;61(5):1846-8.
2001: M Kalbus; Burkhard Fleckenstein; M Offenhäusser; M Blüggel; Arthur Melms; HE Meyer; Hans-Georg Rammensee; Roland Martin; Günther Jung; Norbert Sommer
Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(s).
European journal of immunology 2001;31(2):551-62.
2000: Harpreet Singh-Jasuja; Norbert Hilf; H U Scherer; Danièle Arnold-Schild; Hans-Georg Rammensee; René E M Toes; Hansjörg Schild
The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.
Cell stress & chaperones 2000;5(5):462-70.
2000: Lars Stoltze; Markus Schirle; Gerold Schwarz; Christian J Schröter; M W Thompson; Louis B Hersh; Hubert Kalbacher; Stefan Stevanovic; Hans-Georg Rammensee; Hansjörg Schild
Two new proteases in the MHC class I processing pathway.
Nature immunology 2000;1(5):413-8.
2000: Danièle Arnold-Schild; Christian Kleist; Martin Welschof; Gerhard Opelz; Hans-Georg Rammensee; Hansjörg Schild; Peter Terness
One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
Cancer research 2000;60(15):4175-8.
2000: Markus Schirle; W Keilholz; B Weber; Cécile Gouttefangeas; Tilman Dumrese; Horst D Becker; S Stevanović; Hans-Georg Rammensee
Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.
European journal of immunology 2000;30(8):2216-25.
2000: Harpreet Singh-Jasuja; H U Scherer; Norbert Hilf; Danièle Arnold-Schild; Hans-Georg Rammensee; René E M Toes; Hansjörg Schild
The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor.
European journal of immunology 2000;30(8):2211-5.
2000: Niels P N Emmerich; Alexander K Nussbaum; Stefan Stevanovic; Martin Priemer; René E M Toes; Hans-Georg Rammensee; Hansjörg Schild
The human 26 S and 20 S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate.
The Journal of biological chemistry 2000;275(28):21140-8.
2000: andreas jekle; R Obst; Florian Lang; Hans-Georg Rammensee; Erich Gulbins
CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity.
Biochemical and biophysical research communications 2000;272(2):395-9.
2000: Harpreet Singh-Jasuja; René E M Toes; Pieter Spee; Christian Münz; Norbert Hilf; Stephen P Schoenberger; P Ricciardi-Castagnoli; Jacques Neefjes; Hans-Georg Rammensee; Danièle Arnold-Schild; Hansjörg Schild
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
The Journal of experimental medicine 2000;191(11):1965-74.
2000: Cécile Gouttefangeas; M Diehl; W Keilholz; R F Hörnlein; S Stevanović; Hans-Georg Rammensee
Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.
Blood 2000;95(10):3168-75.
2000: Christina Kuttler; Alexander K Nussbaum; TP Dick; Hans-Georg Rammensee; Hansjörg Schild; Karl-Peter Hadeler
An algorithm for the prediction of proteasomal cleavages.
Journal of molecular biology 2000;298(3):417-29.
2000: Paul Fisch; Arnaud Moris; Hans-Georg Rammensee; Rupert Handgretinger
Inhibitory MHC class I receptors on gammadelta T cells in tumour immunity and autoimmunity.
Immunology today 2000;21(4):187-91.
2000: R Obst; N Netuschil; Karsten Klopfer; S Stevanović; Hans-Georg Rammensee
The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.
The Journal of experimental medicine 2000;191(5):805-12.
2000: Ingmar Hoerr; R Obst; Hans-Georg Rammensee; Günther Jung
In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.
European journal of immunology 2000;30(1):1-7.
1999: Hans-Georg Rammensee; J Bachmann; Niels P N Emmerich; O A Bachor; S Stevanović
SYFPEITHI: database for MHC ligands and peptide motifs.
Immunogenetics 1999;50(3-4):213-9.
1999: FH Seeger; Markus Schirle; W Keilholz; Hans-Georg Rammensee; S Stevanović
Peptide motif of HLA-B*1510.
Immunogenetics 1999;49(11-12):996-9.
1999: Christian Münz; S Stevanović; Hans-Georg Rammensee
Peptide presentation and NK inhibition by HLA-G.
Journal of reproductive immunology 1999;43(2):139-55.
1999: Peter Brossart; K S Heinrich; Gernot Stuhler; L Behnke; Volker L Reichardt; Stefan Stevanovic; A Muhm; Hans-Georg Rammensee; Lothar Kanz; Wolfram Brugger
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
Blood 1999;93(12):4309-17.
1999: FH Seeger; Markus Schirle; J Gatfield; D Arnold; W Keilholz; P Nickolaus; Hans-Georg Rammensee; S Stevanović
The HLA-A*6601 peptide motif: prediction by pocket structure and verification by peptide analysis.
Immunogenetics 1999;49(6):571-6.
1999: P Nickolaus; Hans-Georg Rammensee; R Zawatzky
Molecular cloning of a macrophage-derived, interferon-inducible secreted immunoglobulin-binding protein.
European journal of immunology 1999;29(5):1504-12.
1999: Danièle Arnold-Schild; Daniel Hanau; Danièle Spehner; C Schmid; Hans-Georg Rammensee; Henri de la Salle; Hansjörg Schild
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):3757-60.
1999: Christian Münz; U Naumann; C Grimmel; Hans-Georg Rammensee; Michael Weller
TGF-beta-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells.
European journal of immunology 1999;29(3):1032-40.
1999: Hansjörg Schild; Danièle Arnold-Schild; E Lammert; Hans-Georg Rammensee
Stress proteins and immunity mediated by cytotoxic T lymphocytes.
Current opinion in immunology 1999;11(1):109-13.
1999: Christian Münz; R Obst; Wolfram Osen; S Stevanović; Hans-Georg Rammensee
Alloreactivity as a source of high avidity peptide-specific human CTL.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):25-34.
1998: Lars Stoltze; TP Dick; M Deeg; B Pömmerl; Hans-Georg Rammensee; Hansjörg Schild
Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities.
European journal of immunology 1998;28(12):4029-36.
1998: J Gatfield; E Lammert; P Nickolaus; Christian Münz; Simon Rothenfusser; Paul Fisch; S Stevanović; Hansjörg Schild; Hans-Georg Rammensee; D Arnold
Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules.
International immunology 1998;10(11):1665-72.
1998: Alexander K Nussbaum; TP Dick; W Keilholz; Markus Schirle; S Stevanović; K Dietz; W Heinemeyer; Michael Groll; Dieter H Wolf; Robert Huber; Hans-Georg Rammensee; Hansjörg Schild
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(21):12504-9.
1998: TP Dick; Alexander K Nussbaum; M Deeg; W Heinemeyer; Michael Groll; Markus Schirle; W Keilholz; S Stevanović; Dieter H Wolf; Robert Huber; Hans-Georg Rammensee; Hansjörg Schild
Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants.
The Journal of biological chemistry 1998;273(40):25637-46.
1998: Awen Gallimore; J Hombach; Tilman Dumrese; Hans-Georg Rammensee; Rolf M Zinkernagel; Hans Hengartner
A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
European journal of immunology 1998;28(10):3301-11.
1998: Tilman Dumrese; S Stevanović; FH Seeger; N Yamada; Y Ishikawa; K Tokunaga; M Takiguchi; Hans-Georg Rammensee
HLA-A26 subtype A pockets accommodate acidic N-termini of ligands.
Immunogenetics 1998;48(5):350-3.
1998: TP Dick; S Stevanović; W Keilholz; Thomas Ruppert; Ulrich H Koszinowski; Hansjörg Schild; Hans-Georg Rammensee
The making of the dominant MHC class I ligand SYFPEITHI.
European journal of immunology 1998;28(8):2478-86.
1998: R Obst; Christian Münz; S Stevanović; Hans-Georg Rammensee
Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire.
European journal of immunology 1998;28(8):2432-43.
1998: FH Seeger; D Arnold; Tilman Dumrese; Henri de la Salle; Dominique Fricker; Hansjörg Schild; Hans-Georg Rammensee; S Stevanović
The HLA-B* 1516 motif demonstrates HLA-B-specific P2 pocket characteristics.
Immunogenetics 1998;48(2):156-60.
1998: Awen Gallimore; Tilman Dumrese; Hans Hengartner; Rolf M Zinkernagel; Hans-Georg Rammensee
Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.
The Journal of experimental medicine 1998;187(10):1647-57.
1998: G Malcherek; C Wirblich; N Willcox; Hans-Georg Rammensee; J Trowsdale; Arthur Melms
MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
European journal of immunology 1998;28(5):1524-33.
1998: CM Böhm; Marie-Luise Hanski; S Stefanović; Hans-Georg Rammensee; Harald Stein; J Taylor-Papadimitriou; Ernst-Otto Riecken; Christoph Hanski
Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells.
International journal of cancer. Journal international du cancer 1998;75(5):688-93.
1998: P Nickolaus; Hans-Georg Rammensee; R Zawatzky
Interferon-induced expression of If-1h and If-1l alleles in Newcastle disease virus-infected mouse macrophages is associated with specific differences in viral gene transcription.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(3):187-96.
1998: Peter Brossart; Gernot Stuhler; Thomas Flad; Stefan Stevanovic; Hans-Georg Rammensee; Lothar Kanz; Wolfram Brugger
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Cancer research 1998;58(4):732-6.
1997: Paul Fisch; E Meuer; D Pende; Simon Rothenfusser; O Viale; Sylvia Kock; Soldano Ferrone; D Fradelizi; G Klein; L Moretta; Hans-Georg Rammensee; T Boon; P Coulie; Pierre van der Bruggen
Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
European journal of immunology 1997;27(12):3368-79.
1997: D Arnold; W Keilholz; Hansjörg Schild; Tilman Dumrese; S Stevanović; Hans-Georg Rammensee
Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools.
European journal of biochemistry / FEBS 1997;249(1):171-9.
1997: K Speidel; Wolfram Osen; Stefan Faath; I Hilgert; R Obst; J Braspenning; Frank Momburg; Günter J Hämmerling; Hans-Georg Rammensee
Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses.
European journal of immunology 1997;27(9):2391-9.
1997: D Arnold; C Wahl; S Faath; Hans-Georg Rammensee; Hansjörg Schild
Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
The Journal of experimental medicine 1997;186(3):461-6.
1997: D Arnold; W Keilholz; Hansjörg Schild; Tilman Dumrese; S Stevanović; Hans-Georg Rammensee
Evolutionary conserved cathepsin E substrate specificity as defined by N-terminal and C-terminal sequencing of peptide pools.
Biological chemistry 1997;378(8):883-91.
1997: E Lammert; S Stevanović; J Brunner; Hans-Georg Rammensee; Hansjörg Schild
Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum.
European journal of immunology 1997;27(7):1685-90.
1997: Ingrid Jochmus; Wolfram Osen; Annette Altmann; G Buck; B Hofmann; Achim Schneider; Lutz Gissmann; Hans-Georg Rammensee
Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
The Journal of general virology 1997;78 ( Pt 7)():1689-95.
1997: Carmen Scheibenbogen; KH Lee; S Stevanovic; Mathias Witzens; Martina Willhauck; V Waldmann; Helmut Naeher; Hans-Georg Rammensee; Ulrich Keilholz
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay.
International journal of cancer. Journal international du cancer 1997;71(6):932-6.
1997: Henri de la Salle; Elisabeth Houssaint; Marie-Alix Peyrat; D Arnold; Jean Salamero; D Pinczon; Stefan Stevanovic; Huguette Bausinger; Dominique Fricker; E Gomard; W Biddison; P Lehner; F UytdeHaag; M Sasportes; Lionel Donato; Hans-Georg Rammensee; Jean-Pierre Cazenave; Daniel Hanau; MM Tongio; Marc Bonneville
Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(10):4555-63.
1997: J L Maryanski; J L Casanova; K Falk; H Gournier; C Jaulin; P Kourilsky; F A Lemonnier; R Lüthy; Hans-Georg Rammensee; Olaf Rötzschke; Catherine Servis; J A López
The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized.
Human immunology 1997;54(2):117-28.
1997: E Lammert; D Arnold; M Nijenhuis; Frank Momburg; Günter J Hämmerling; J Brunner; S Stevanović; Hans-Georg Rammensee; Hansjörg Schild
The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP.
European journal of immunology 1997;27(4):923-7.
1997: Christian Münz; N Holmes; A King; Y W Loke; Marco COLONna; Hansjörg Schild; Hans-Georg Rammensee
Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells.
The Journal of experimental medicine 1997;185(3):385-91.
1997: Carmen Scheibenbogen; KH Lee; S Mayer; S Stevanovic; U Moebius; W Herr; Hans-Georg Rammensee; Ulrich Keilholz
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):221-6.
1996: Frode Vartdal; B H Johansen; T Friede; Christopher Thorpe; S Stevanović; J E Eriksen; K Sletten; Erik Thorsby; Hans-Georg Rammensee; Ludvig M Sollid
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
European journal of immunology 1996;26(11):2764-72.
1996: S Mayer; Carmen Scheibenbogen; K H Lee; W Keilholz; Stefan Stevanovic; Hans-Georg Rammensee; Ulrich Keilholz
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides.
Journal of immunological methods 1996;197(1-2):131-7.
1996: TP Dick; T Ruppert; Marcus Groettrup; Peter-M Kloetzel; L Kuehn; Ulrich H Koszinowski; S Stevanović; Hansjörg Schild; Hans-Georg Rammensee
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.
Cell 1996;86(2):253-62.
1996: T Friede; V Gnau; G Jung; W Keilholz; S Stevanović; Hans-Georg Rammensee
Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides.
Biochimica et biophysica acta 1996;1316(2):85-101.
1996: Marcus Groettrup; Alejandro Soza; M Eggers; L Kuehn; TP Dick; Hansjörg Schild; Hans-Georg Rammensee; Ulrich H Koszinowski; Peter-M Kloetzel
A role for the proteasome regulator PA28alpha in antigen presentation.
Nature 1996;381(6578):166-8.
1996: E Lammert; D Arnold; Hans-Georg Rammensee; Hansjörg Schild
Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
European journal of immunology 1996;26(4):875-9.
1996: M Diehl; Christian Münz; W Keilholz; S Stevanović; N Holmes; Y W Loke; Hans-Georg Rammensee
Nonclassical HLA-G molecules are classical peptide presenters.
Current biology : CB 1996;6(3):305-14.
1996: A Steinle; K Falk; O Rötzschke; V Gnau; S Stevanović; G Jung; Dolores Schendel; Hans-Georg Rammensee
Motif of HLA-B*3503 peptide ligands.
Immunogenetics 1996;43(1-2):105-7.
1995: Hansjörg Schild; U Grüneberg; G Pougialis; H J Wallny; W Keilholz; S Stevanović; Hans-Georg Rammensee
Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules.
International immunology 1995;7(12):1957-65.
1995: D Barouch; T Friede; S Stevanović; L Tussey; K Smith; S Rowland-Jones; Veronique M Braud; Andrew McMichael; Hans-Georg Rammensee
HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
The Journal of experimental medicine 1995;182(6):1847-56.
1995: D Arnold; Stefan Faath; Hans-Georg Rammensee; Hansjörg Schild
Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
The Journal of experimental medicine 1995;182(3):885-9.
1995: G Malcherek; V Gnau; G Jung; Hans-Georg Rammensee; Arthur Melms
Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
The Journal of experimental medicine 1995;181(2):527-36.
1995: Hans-Georg Rammensee
Chemistry of peptides associated with MHC class I and class II molecules.
Current opinion in immunology 1995;7(1):85-96.
1995: K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; Hans-Georg Rammensee
Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.
International immunology 1995;7(2):223-8.
1995: A I Bamford; A Douglas; T Friede; Stefan Stevanovic; Hans-Georg Rammensee; Brian M Adair
Peptide motif of a cattle MHC class I molecule.
Immunology letters 1995;45(1-2):129-36.
1995: Hans-Georg Rammensee; T Friede; S Stevanoviíc
MHC ligands and peptide motifs: first listing.
Immunogenetics 1995;41(4):178-228.
1995: K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; Hans-Georg Rammensee
Peptide motifs of HLA-B58, B60, B61, and B62 molecules.
Immunogenetics 1995;41(2-3):165-8.
1995: K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; Hans-Georg Rammensee
Peptide motifs of HLA-B38 and B39 molecules.
Immunogenetics 1995;41(2-3):162-4.
1994: S Stevanović; Hans-Georg Rammensee
Identification of T-cell epitopes using allele-specific ligand motifs.
Behring Institute Mitteilungen 1994;(95):7-13.
1994: Anne B Vogt; Harald Kropshofer; Hubert Kalbacher; M Kalbus; Hans-Georg Rammensee; John E Coligan; Roland Martin
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(4):1665-73.
1994: G Malcherek; V Gnau; Stefan Stevanovic; Hans-Georg Rammensee; G Jung; Arthur Melms
Analysis of allele-specific contact sites of natural HLA-DR17 ligands.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(3):1141-9.
1994: Hans-Georg Rammensee
How the quest to identify minor histocompatibility antigens led to something more important.
Behring Institute Mitteilungen 1994;(94):11-6.
1994: K Falk; O Rötzschke; S Stevanović; V Gnau; Katrin Sparbier; G Jung; Hans-Georg Rammensee; Peter Walden
Analysis of a naturally occurring HLA class I-restricted viral epitope.
Immunology 1994;82(3):337-42.
1994: O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; Hans-Georg Rammensee
Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.
Immunogenetics 1994;39(1):74-7.
1994: K Falk; O Rötzschke; S Stevanović; G Jung; Hans-Georg Rammensee
Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.
Immunogenetics 1994;39(4):230-42.
1994: K Falk; O Rötzschke; M Takiguchi; B Grahovac; V Gnau; S Stevanović; G Jung; Hans-Georg Rammensee
Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules.
Immunogenetics 1994;40(3):238-41.
1994: R Maier; K Falk; O Rötzschke; B Maier; V Gnau; S Stevanović; G Jung; Hans-Georg Rammensee; Andreas Meyerhans
Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.
Immunogenetics 1994;40(4):306-8.
1993: K Falk; O Rötzschke; B Grahovac; Dolores Schendel; S Stevanović; V Gnau; G Jung; Jack L Strominger; Hans-Georg Rammensee
Allele-specific peptide ligand motifs of HLA-C molecules.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):12005-9.
1993: K Deres; Werner Beck; S Faath; G Jung; Hans-Georg Rammensee
MHC/peptide binding studies indicate hierarchy of anchor residues.
Cellular immunology 1993;151(1):158-67.
1993: G Malcherek; K Falk; O Rötzschke; Hans-Georg Rammensee; S Stevanović; V Gnau; G Jung; Arthur Melms
Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.
International immunology 1993;5(10):1229-37.
1993: K Falk; O Rötzschke; S Faath; S Goth; I Graef; Nilabh Shastri; Hans-Georg Rammensee
Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL.
Cellular immunology 1993;150(2):447-52.
1993: M Norda; K Falk; O Rötzschke; S Stevanović; G Jung; Hans-Georg Rammensee
Comparison of the H-2Kk- and H-2Kkm1-restricted peptide motifs.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(2):144-9.
1993: O Rötzschke; K Falk; S Stevanović; B Grahovac; Mark J Soloski; G Jung; Hans-Georg Rammensee
Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.
Nature 1993;361(6413):642-4.
1993: K Falk; O Rötzschke; B Grahovac; Dolores Schendel; S Stevanović; G Jung; Hans-Georg Rammensee
Peptide motifs of HLA-B35 and -B37 molecules.
Immunogenetics 1993;38(2):161-2.
1992: H J Wallny; K Deres; S Faath; G Jung; A Van Pel; T Boon; Hans-Georg Rammensee
Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.
International immunology 1992;4(10):1085-90.
1992: O Rötzschke; K Falk; S Stevanović; G Jung; Hans-Georg Rammensee
Peptide motifs of closely related HLA class I molecules encompass substantial differences.
European journal of immunology 1992;22(9):2453-6.
1992: K Falk; O Rötzschke; Hans-Georg Rammensee
Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man.
European journal of immunology 1992;22(5):1323-6.
1992: K Falk; O Rötzschke; Hans-Georg Rammensee
A self peptide naturally presented by both H-2Kb and H-2Kbm1 molecules demonstrates MHC restriction of self tolerance at the molecular level.
International immunology 1992;4(3):321-5.
1992: H J Wallny; O Rötzschke; K Falk; Günter J Hämmerling; Hans-Georg Rammensee
Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing.
European journal of immunology 1992;22(3):655-9.
1991: Hansjörg Schild; M Norda; K Deres; K Falk; O Rötzschke; KH Wiesmüller; G Jung; Hans-Georg Rammensee
Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.
The Journal of experimental medicine 1991;174(6):1665-8.
1991: O Rötzschke; K Falk; S Faath; Hans-Georg Rammensee
On the nature of peptides involved in T cell alloreactivity.
The Journal of experimental medicine 1991;174(5):1059-71.
1991: Hansjörg Schild; K Deres; KH Wiesmüller; G Jung; Hans-Georg Rammensee
Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells.
European journal of immunology 1991;21(11):2649-54.
1991: O Rötzschke; K Falk; S Stevanović; G Jung; Peter Walden; Hans-Georg Rammensee
Exact prediction of a natural T cell epitope.
European journal of immunology 1991;21(11):2891-4.
1991: Vincenzo Cerundolo; Tim Elliott; J Elvin; J Bastin; Hans-Georg Rammensee; A Townsend
The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
European journal of immunology 1991;21(9):2069-75.
1991: K Falk; O Rötzschke; K Deres; J Metzger; G Jung; Hans-Georg Rammensee
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
The Journal of experimental medicine 1991;174(2):425-34.
1991: K Falk; O Rötzschke; S Stevanović; G Jung; Hans-Georg Rammensee
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
Nature 1991;351(6324):290-6.
1991: P Griem; H J Wallny; K Falk; O Rötzschke; Bernd Arnold; G Schönrich; Günter J Hämmerling; Hans-Georg Rammensee
Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression.
Cell 1991;65(4):633-40.
1991: Hans-Georg Rammensee
Maintenance of self tolerance in CD4+ T lymphocytes by antigen presentation on resting B cells--a hypothesis.
Bone marrow transplantation 1991;7 Suppl 1():26-8.
1990: O Rötzschke; K Falk; K Deres; Hansjörg Schild; M Norda; J Metzger; G Jung; Hans-Georg Rammensee
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
Nature 1990;348(6298):252-4.
1990: O Rötzschke; K Falk; H J Wallny; S Faath; Hans-Georg Rammensee
Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y.
Science (New York, N.Y.) 1990;249(4966):283-7.
1990: H Schild; O Rötzschke; H Kalbacher; Hans-Georg Rammensee
Limit of T cell tolerance to self proteins by peptide presentation.
Science (New York, N.Y.) 1990;247(4950):1587-9.
1989: K Deres; Hansjörg Schild; KH Wiesmüller; G Jung; Hans-Georg Rammensee
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.
Nature 1989;342(6249):561-4.
1989: Hans-Georg Rammensee; R Kroschewski; B Frangoulis
Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.
Nature 1989;339(6225):541-4.
1989: B Frangoulis; Marika Pla; Hans-Georg Rammensee
Alternative T cell receptor gene usage induced by self tolerance.
European journal of immunology 1989;19(3):553-5.
1989: Hans-Georg Rammensee; Hansjörg Schild; U Theopold
Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.
Immunogenetics 1989;30(4):296-302.